FindTrial
Sign In

Germline genomics etiology of breast cancer and its application in the early prevention of breast cancer

Germline genomics etiology of breast cancer and its application in the early prevention of breast cancer

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100043705
Enrollment
Unknown
Registered
2021-02-27
Start date
2021-03-01
Completion date
Unknown
Last updated
2021-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Gold Standard:Pathological diagnosis of breast cancer/breast ductal papilloma/dysplasia/breast ductal carcinoma/lobular carcinoma
Index test:Flow&#32
cytometry,&#32
whole&#32
exome&#32
sequencing,&#32
pathological&#32
immunohistochemistry

Sponsors

Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Women aged 18-85 years.

Exclusion criteria

Exclusion criteria: People who don't want to participate.

Design outcomes

Primary

MeasureTime frame
APSP;immune cells;SEN, SPE, ACC, AUC of ROC;—

Countries

China

Contacts

Public ContactMei Yang

Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences

yangmei286@163.com+86 13725421149

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026